Tufts Launchpad | BioLabs retweeted
Exciting news! @BioLabs & @LabCentral have been chosen as the winner of the 2022 #PrixGalien USA Awards, in the “Incubators, Accelerators & Equity” category. It’s an honor to be recognized for our mission to create scientific spaces that fuel innovation.
labcentral.site/prix2
Tufts Launchpad | BioLabs retweeted
We were honored to receive the inaugural @GalienFdn award for "Incubators, Accelerators, and Equity". We share this milestone with all our partners, sponsors and startups who push the boundaries of #innovation every day!
biolabs.io/post/biolabs-and-…
Tufts Launchpad | BioLabs retweeted
Are you a #lifescience #startup in the #Boston-#Cambridge area looking for #labspace? Learn more about upcoming availability at Tufts Launchpad @biolabs, here in downtown Boston!
Check out our new brochure here: bit.ly/3Odrsqu
And apply here: biolabs.io/apply-online
Tufts Launchpad | BioLabs retweeted
Look back at our recent immersion in Boston during March'22🇺🇸🇫🇷 👉🏼france-science.com/la-semain…
Really fruitful meetings with inspiring people @MALifeSciences @Nanobiotix @treefrogtx @seabelife @CeresBrain @Diagnoly @BioLabsBoston @MassBio Thanks @Netva_fr and @FranceinBoston 🙏🏻
📖 #TBT - #Boston : Retour sur l’immersion en mars 2022 des startups lauréates #NETVA en 2021🇫🇷 🇺🇸.france-science.com/la-semain…
Tufts Launchpad | BioLabs retweeted
We joined @BioLabsBoston & @NMHS_TITANS for a session of the BioLabs' Biotech & Life Sciences Immersion Program. The program helps students learn from biotech leaders and better understand the many applications of a STEM education. We had a great time doing a hands-on experience!
Tufts Launchpad | BioLabs retweeted
Great day learning about #genetics and #geneediting technologies with @BostonSchools during yesterday’s session of @biolabs Biotech & Life Sciences Immersion Program. @BioLabsBoston
Tufts Launchpad | BioLabs retweeted
Highlights from Q1 2022: Ovid anticipates filing IND for OV329 for #epilepsy & #seizures and plans to initiate Phase 1 trials in Q4 2022. We also expect to present preclinical data on OV329 at EILAT XVI and the @EpilepsyFdn Pipeline Conference. Read more: investors.ovidrx.com/news-re…
Tufts Launchpad | BioLabs retweeted
Our own @fvigno2 will be joining a @LifeScienceWA Innovation Northwest 2022 panel on 4/21 to share his insights on "Turning New Technologies into Medicines." Join this session to hear the latest updates on RNA editing and experimental therapeutics #LSINW22 bit.ly/3jCvVG0
Tufts Launchpad | BioLabs retweeted
Join us Apr. 19, 4pm ET for the next De-Risking Biotech event, Fundraising Diligence for Angels, Seed Ventures, Friends & Family, featuring Benji Leibowitz - @KdT_Ventures, Ana-Maria Visoiu - @GoldenSeeds and Sandra Cohen - Cohen & Buckmann PC!
Register: bit.ly/3uIgNfw
Tufts Launchpad | BioLabs retweeted
Tomorrow, our chairman and CEO @jmaxlevin will be joining industry leaders at the 11th Annual R&D Leadership Conference, The Future of Precision Medicine, to discuss ongoing developments in drug discovery. Learn more: bit.ly/3MTgoz1
Tufts Launchpad | BioLabs retweeted
We’re pleased to announce that Ovid management will be presenting at the 21st Annual Needham Virtual Healthcare Conference next week. Join us on April 14th for a live webcast of the virtual presentation, which can be accessed at investors.ovidrx.com. investors.ovidrx.com/news-re…
Tufts Launchpad | BioLabs retweeted
Today @AstellasUS #PharmaDays event @MassBio, @Axonis_US will share our experience as #Golden #Ticket Winners. Our CSO & Co-Founder @SVH_neuro will dicuss how we received invaluable access to exellent feedback, support & guidance from Astellas team, & prime lab space @labcentral
Last chance! Register for the @AstellasUS #PharmaDays event on Wednesday where you will hear about the company's partnering capabilities, followed by a networking reception with MassBio's #innovation community: massbio.org/events/listing/a…
Tufts Launchpad | BioLabs retweeted
Our CSO David Huss and Head of Platform Technologies @AdrianWBriggs will be presenting on the therapeutic potential of RNA editing and delivery considerations for RNA editing payloads at the 3rd Annual RNA Editing Summit. Register with discount code SK10: rnaediting-summit.com/
Tufts Launchpad | BioLabs retweeted
We're looking for a #principalscientist or #associatedirector of pharmacology toxicology to help our teams develop novel viral-based genomic medicines for hematological disorders. Check out the key responsibilities of this role below, and learn more here. bit.ly/36RpCeC
Tufts Launchpad | BioLabs retweeted
🇺🇸/🇫🇷 Boston day #3 Yet another fruitful day, rich of new meeting a in the framework of @Netva_fr
Was also great to meet our colleagues from @VCLSsocial and to visit @biolabs @BioLabsBoston @TuftsMedicalCtr
Tufts Launchpad | BioLabs retweeted
"Together we are accomplishing something transformational" @JFruehauf. BioLabs is building not only infrastructure, we are building community for entrepreneurs in North Texas @BioLabsNTX launch
Tufts Launchpad | BioLabs retweeted
Yesterday, Ovid reported our fourth quarter, year-end 2021 financial results, which reaffirm our commitment to advancing a pipeline focused on #epilepsy and seizure-related disorders. Read more: investors.ovidrx.com/news-re…
Tufts Launchpad | BioLabs retweeted
We are proud to announce that enrollment for KONFIDENT, a Phase 3 Clinical Trial for our investigational candidate KVD900, for on-demand
treatment of #HereditaryAngioedema attacks has started. #HAE #OralOptions4HAE
konfidentstudy.com/
Tufts Launchpad | BioLabs retweeted
Breaking News: A new, two-dose Covid vaccine, made by the Europe-based pharmaceutical companies Sanofi and GSK, showed 100% efficacy against severe disease, and may be an effective booster for other shots, its makers said. nyti.ms/3sctRcK